The knockdown of miR-939 may inhibit cell proliferation and invasion by regulating the expression of TIMP2 in NSCLC cells, and miR-939 may be a potential target for the treatment of NSCLC, although it requires further study [39]. Here, TIMP2 is linked to non-small cell lung carcinoma.